News
Merck's KEYTRUDA Combo Cuts Risk By 35% In First-Line PD-L1+ Metastatic TNBC, Phase 3 Study Confirms
(RTTNews) - Merck & Co Inc. (MRK) announced that KEYTRUDA (pembrolizumab) plus Trodelvy (sacituzumab govitecan-hziy) reduced the risk of disease progression or death by 35% compared to KEYTRUDA plus c ...
C3.ai (NYSE:AI) is a technology company listed on the NYSE and included in the Top Nasdaq Stocks. As a player in the ...
Enhanced International Dividend Trust operates within the asset management segment of the financial services industry.
SkyWest (NASDAQ:SWKS) operates within the transportation sector and its recent stock performance can be compared against ...
Highlights,Nano Nuclear Energy shares declined following a private placement offering.,The offering caused dilution concerns ...
Nuveen Asset Management LLC (NYSE:EVTC) recently adjusted its of EVERTEC, Inc., a company listed on the NYSE Composite.
Aptorum Group Limited (NASDAQ:APM) operates within the pharmaceutical and healthcare sector, with its shares listed on Nasdaq ...
Highlights,Calidi Biotherapeutics shares declined during recent trading activity,Volume significantly reduced compared to ...
Shares of Newsmax Media, (NYSE:NMAX) a media company listed on the exchange, saw a notable decrease during trading. This ...
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) operates within the biotechnology sector and is publicly traded on the NASDAQ ...
Wynn Resorts, Limited (NASDAQ:WYNN) operates within the hospitality and gaming industry, primarily listed under the NASDAQ ...
DraftKings, (NASDAQ:DKNG) a company in the digital sports entertainment and online gaming sector, is currently listed under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results